Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis. Scope of the Report: This report focuses on the Pitavastatin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers CR Double-Crane Pharmaceuticals Kowa Pharmaceuticals Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers 1 mg 2 mg 5 mg Market Segment by Applications, can be divided into Hypercholesterolaemia Cardiovascular Disease Diabetes Others There are 15 Chapters to deeply display the global Pitavastatin market. Chapter 1, to describe Pitavastatin Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Pitavastatin, with sales, revenue, and price of Pitavastatin, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Pitavastatin, for each region, from 2012 to 2017; Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 12, Pitavastatin market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 13, 14 and 15, to describe Pitavastatin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Pitavastatin Introduction 1.2 Market Analysis by Type 1.2.1 1 mg 1.2.2 2 mg 1.2.3 5 mg 1.3 Market Analysis by Applications 1.3.1 Hypercholesterolaemia 1.3.2 Cardiovascular Disease 1.3.3 Diabetes 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (USA,
